Tiglutik (riluzole) Oral Suspension 50 mg/10 mL (5 mg/mL), 600 mL (two bottles/300 mL each) recall — FDA D-0115-2024
Failed Viscosity Specifications: Out-of-specification test results for viscosity
Overview of recall records associated with ITF PHARMA Inc., including dates, categories and classifications where available.
Classification mix: Class II: 1.
Failed Viscosity Specifications: Out-of-specification test results for viscosity
This page summarizes recall records in which the official source identifies ITF PHARMA Inc. as the recalling firm or manufacturer. The number of records should not be treated as a safety rating or a measure of company size, because recall counts depend on product mix, reporting periods and how government records are organized.
Compare the dates, categories and classifications together rather than relying on the total alone. Open an individual record for the recalled product, reason, distribution details and current instructions available from the source.